{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:12:14Z","timestamp":1772554334757,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ejpb.2019.04.003","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T20:39:30Z","timestamp":1554496770000},"page":"224-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Targeted chemo-sonodynamic therapy treatment of breast tumours using ultrasound responsive microbubbles loaded with paclitaxel, doxorubicin and Rose Bengal"],"prefix":"10.1016","volume":"139","author":[{"given":"Keiran","family":"Logan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Foglietta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Nesbitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjie","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"McKaig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukanta","family":"Kamila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolitsa","family":"Nomikou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridgeen","family":"Callan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony P.","family":"McHale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Callan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2019.04.003_b0005","unstructured":"Cancer Research UK. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer (accessed 2 July 2018)."},{"key":"10.1016\/j.ejpb.2019.04.003_b0010","unstructured":"Lawrence G, Kearins O, Lagord C, Cheung S, Sidhu J, Sagar J.The Second All Breast Cancer Report. (accessed 2 July 2018). <http:\/\/www.ncin.org.uk\/view.aspx?rid=612>."},{"issue":"10","key":"10.1016\/j.ejpb.2019.04.003_b0015","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/bjs.5894","article-title":"Neoadjuvant chemotherapy for operable breast cancer","volume":"94","author":"Mieog","year":"2007","journal-title":"British J. Surgery"},{"issue":"6","key":"10.1016\/j.ejpb.2019.04.003_b0020","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1200\/JCO.1991.9.6.1059","article-title":"The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review","volume":"9","author":"Kiebert","year":"1991","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ejpb.2019.04.003_b0025","first-page":"27","article-title":"Trialists\u2019 Collaborative Group (EBCTCG). Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from randomised trials","volume":"19","author":"Early Breast Cancer","year":"2017","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.ejpb.2019.04.003_b0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1081\/CNV-100000150","article-title":"Doxorubicin and paclitaxel in the treatment of advanced breast cancer: efficacy and cardiac considerations","volume":"19","author":"Perez","year":"2001","journal-title":"Cancer Invest."},{"issue":"10","key":"10.1016\/j.ejpb.2019.04.003_b0035","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1517\/17425247.5.10.1121","article-title":"Ultrasound targeted microbubble destruction for drug and gene delivery","volume":"5","author":"Mayer","year":"2008","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"2","key":"10.1016\/j.ejpb.2019.04.003_b0040","first-page":"90","article-title":"Contrast echocardiography 1996","volume":"23","author":"Villarraga","year":"1996","journal-title":"A review. Texas Heart Institute"},{"issue":"6","key":"10.1016\/j.ejpb.2019.04.003_b0045","first-page":"429","article-title":"Microbubble ultrasound contrast agents: a review proceedings of the institution of mechanical engineers","volume":"217","author":"Stride","year":"2003","journal-title":"Part H: J. Eng. Med."},{"key":"10.1016\/j.ejpb.2019.04.003_b0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biomaterials.2015.11.033","article-title":"Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle","volume":"80","author":"McEwan","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2019.04.003_b0055","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1039\/c2cc33913g","article-title":"Microbubble-sonosensitiser conjugates as therapeutics in sonodynamic therapy","volume":"67","author":"Nomikou","year":"2012","journal-title":"Chem. Commun."},{"issue":"19","key":"10.1016\/j.ejpb.2019.04.003_b0060","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1016\/j.bmcl.2011.08.015","article-title":"Enhanced ROS production and cell death through combined photo- and sono-activation of conventional photosensitising drugs","volume":"21","author":"McCaughan","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"49","key":"10.1016\/j.ejpb.2019.04.003_b0065","doi-asserted-by":"crossref","first-page":"14926","DOI":"10.1021\/la503929c","article-title":"Polymeric microbubbles as delivery vehicles for sensitizers in sonodynamic therapy","volume":"30","author":"McEwan","year":"2014","journal-title":"Langmuir"},{"issue":"9","key":"10.1016\/j.ejpb.2019.04.003_b0070","first-page":"3361","article-title":"Sonodynamically induced cell damage using rose bengal derivative","volume":"30","author":"Sugita","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejpb.2019.04.003_b0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2015.02.004","article-title":"Oxygen carrying microbubbles for enhanced sonodynamic therapy of hypoxic tumours","volume":"203","author":"McEwan","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.04.003_b0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2018.04.018","article-title":"Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer","volume":"279","author":"Nesbitt","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.04.003_b0085","series-title":"Taxol: Science and Applications","first-page":"237","article-title":"\u201cBiopharmaceutics of paclitaxel (Taxol): formulation, activity and pharmacokinetics\u201d","author":"Straubinger","year":"1996"},{"issue":"45","key":"10.1016\/j.ejpb.2019.04.003_b0090","doi-asserted-by":"crossref","first-page":"13987","DOI":"10.1021\/ja0749744","article-title":"Enhancing the stability and biological functionalities of quantum dots via compact multifunctional ligands","volume":"129","author":"Susumu","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejpb.2019.04.003_b0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2016.10.007","article-title":"A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer","volume":"243","author":"Dimcevski","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.04.003_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2016.12.032","article-title":"Ultrasound-mediated destruction of oxygen and paclitaxel loaded dual-targeting microbubbles for intraperitoneal treatment of ovarian cancer xenografts","volume":"391","author":"Luo","year":"2017","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.ejpb.2019.04.003_b0105","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.acra.2008.06.013","article-title":"Treatment of xenografted ovarian carcinoma using paclitaxel-loaded ultrasound microbubbles","volume":"15","author":"Xing","year":"2008","journal-title":"Acad. Radiol."},{"issue":"9","key":"10.1016\/j.ejpb.2019.04.003_b0110","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.addr.2003.12.006","article-title":"Therapeutic applications of lipid-coated microbubbles","volume":"56","author":"Unger","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.ejpb.2019.04.003_b0115","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1590\/1414-431X20132647","article-title":"A spheroid-based 3-D culture model for pancreatic cancer drug testing, using the acid phosphatase assay","volume":"46","author":"Wen","year":"2013","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"5","key":"10.1016\/j.ejpb.2019.04.003_b0120","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ultrasmedbio.2008.10.013","article-title":"Sonoporation by ultrasound-activated microbubble contrast agents: effect of acoustic exposure parameters on cell membrane permeability and cell viability","volume":"35","author":"Karshafian","year":"2009","journal-title":"Ultrasound Med. Biol."},{"issue":"6","key":"10.1016\/j.ejpb.2019.04.003_b0125","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ultrasmedbio.2004.02.010","article-title":"Ultrasound-induced encapsulated microbubble phenomena","volume":"30","author":"Postema","year":"2004","journal-title":"Ultrasound Med. Biol."},{"issue":"9","key":"10.1016\/j.ejpb.2019.04.003_b0130","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ultrasmedbio.2004.07.015","article-title":"Micromanipulation of endothelial cells: Ultrasound-microbubble-cell interaction","volume":"30","author":"van Wamel","year":"2004","journal-title":"Ultrasound Med. Biol."},{"issue":"2","key":"10.1016\/j.ejpb.2019.04.003_b0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2006.02.007","article-title":"Vibrating microbubbles poking individual cells: Drug transfer into cells via sonoporation","volume":"112","author":"van Wamel","year":"2006","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ejpb.2019.04.003_b0140","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/nprot.2006.238","article-title":"Analysis of apoptosis by propidium iodide staining and flow cytometry","volume":"1","author":"Riccardi","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejpb.2019.04.003_b0145","first-page":"1","article-title":"Clinical toxicities encountered with paclitaxel (Taxol)","volume":"20","author":"Rowinsky","year":"1993","journal-title":"Semin. Oncol."},{"issue":"12","key":"10.1016\/j.ejpb.2019.04.003_b0150","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.1994.12.12.2654","article-title":"European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion","volume":"12","author":"Eisenhauer","year":"1994","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ejpb.2019.04.003_b0155","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/jnci\/90.4.300","article-title":"Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study","volume":"90","author":"Szebeni","year":"1998","journal-title":"J. Natl Cancer Inst."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119300840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119300840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T10:17:54Z","timestamp":1556705874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641119300840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":31,"alternative-id":["S0939641119300840"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.04.003","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted chemo-sonodynamic therapy treatment of breast tumours using ultrasound responsive microbubbles loaded with paclitaxel, doxorubicin and Rose Bengal","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}